
RPRX vs GMAB
$RPRX vs $GMAB head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
RPRX vs GMAB: the quick read
- ·RPRX is the larger company by market cap ($26.01B vs $21.36B).
- ·RPRX has been more active on our scanner (70 vs 48 alerts in 30 days).
- ·RPRX has the smaller float (336.4M vs 613.9M), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (PHARMACEUTICAL PREPARATIONS vs Pharmaceutical Preparations), so they answer to different catalysts and a move in one says little about the other.
- ·Both stay busy on our scanner, 70 and 48 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·They are closely matched in size, within 22% of each other on market cap, which makes the rest of this table the interesting part.
- ·Both are trading in the upper quarter of their 52-week range, so neither is a pullback candidate right now.
- ·RPRX pays a dividend and GMAB does not, which usually means one is being held for income and the other for the move.
- ·RPRX is the one in play today, trading about 2.4x its normal volume, which is what puts a name on our scanner in the first place.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing RPRX and GMAB on TheDesperateTrader.
- Is RPRX or GMAB the better stock?
- "Better" depends on your goal, and these two are not alike. RPRX is the larger company by market cap ($26.01B vs $21.36B). RPRX has been more active on our scanner (70 vs 48 alerts in 30 days). RPRX has the smaller float (336.4M vs 613.9M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between RPRX and GMAB?
- The differences that matter: they are not in the same business - RPRX is pharmaceutical preparations and GMAB is pharmaceutical preparations; they are similar in size ($26.01B vs $21.36B); they trade at very different share prices ($58.42 vs $34.73); RPRX sits at 80% of its 52-week range against 94% for GMAB; only RPRX pays a dividend; our scanner flagged RPRX 70 times in the last 30 days against 48 for GMAB. Everything above is measured from the latest completed session and SEC filings.
- Which of RPRX and GMAB is more active right now?
- Right now RPRX is at about 2.4x its normal volume and GMAB is at about 1.1x, so RPRX is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading RPRX or GMAB? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore RPRX and GMAB comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.